Ceramide as a mediator of non-alcoholic fatty liver disease and associated atherosclerosis

Keyphrases

• Non-alcoholic Fatty Liver Disease (NAFLD) 100%
• Ceramide 100%
• Apolipoprotein B (Apo B) 60%
• Plasma Ceramides 60%
• Western Diet 40%
• Ceramide Synthesis 40%
• Long-chain Ceramide 40%
• Sphingomyelin 40%
• Myriocin 40%
• Dyslipidemia 20%
• Lipid Metabolism 20%
• Apoptosis 20%
• Gene Expression 20%
• Comorbidity 20%
• Protein Expression 20%
• Hepatic Steatosis 20%
• Independent Risk Factors 20%
• Cardiovascular Disease 20%
• Low-density Lipoprotein Receptor 20%
• Oxidative Stress 20%
• Apolipoprotein A-I (ApoA-I) 20%
• Hepatic Fibrosis 20%
• Risk Factors for Cardiovascular Diseases 20%
• Insulin Signaling 20%
• Hepatocyte Apoptosis 20%
• Lipid Kinetics 20%
• Lipoprotein Metabolism 20%
• Lipogenesis 20%
• Insulin Metabolism 20%
• Diet-induced 20%
• Induced Models 20%
• Lipoprotein Kinetics 20%
• Very-long-chain 20%
• Inflammation Apoptosis 20%
• Hepatic Oxidative Stress 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Nonalcoholic Fatty Liver 100%
• Atherosclerosis 100%
• Ceramide 100%
• Lipoprotein 20%
• Sphingomyelin 20%
• Thermozymocidin 20%
• Cardiovascular Disease 20%
• Dyslipidemia 10%
• Inflammation 10%
• Fibrosis 10%
• Very Low Density Lipoprotein 10%
• Low Density Lipoprotein Receptor Knockout Mouse 10%
• Fatty Liver 10%
• Comorbidity 10%

Biochemistry, Genetics and Molecular Biology

• Mediator 100%
• Ceramide 100%
• Blood Plasma 40%
• Programmed Cell Death 30%
• Oxidative Stress 20%
• Myriocin 20%
• Sphingomyelin 20%
• Lipid Metabolism 10%
• Dyslipidemia 10%
• Lipid 10%
• Lipoprotein 10%
• Metabolite 10%
• Lipogenesis 10%
• Lipoprotein Metabolism 10%
• Insulin Metabolism 10%
• Insulin Signaling 10%
• Low Density Lipoprotein Receptor Knockout Mouse 10%
• Comorbidity 10%